Net Cash Provided by (Used in) Operating Activities |
58.7M |
USD |
+224% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-35.4M |
USD |
-0.86% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-74.8M |
USD |
+29.8% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
60.5M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-51.5M |
USD |
+58.3% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Payments to Acquire Property, Plant, and Equipment |
2.6M |
USD |
-25.7% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
847M |
USD |
|
Q3 2024 |
Q3 2024 |
Deferred Income Tax Expense (Benefit) |
-17.5M |
USD |
+31.6% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Current Income Tax Expense (Benefit) |
129M |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
1.3M |
USD |
-40.9% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
311M |
USD |
-9.93% |
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
30.7M |
USD |
-1.29% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |